Patents Represented by Attorney R. Brian McCaslin

Find this attorney in the Justia Lawyer Directory

  • Therapeutic use for treating of leukemia
    Patent number: 8236811
    Abstract: The disclosure relates to methods of treating leukaemia, in particular myeloid leukaemia, comprising administering the compound N-[2-(2,1,3-benzothiadiazol-5-ylamino)-6-(2,6-dichlorophenyl)pyrido[2,3-d]pyrimidin-7-yl]-N?-(1,1-dimethylethyl)-urea or a hydrate, a pharmaceutically acceptable salt or a solvate thereof.
    Type: Grant
    Filed: June 16, 2009
    Date of Patent: August 7, 2012
    Assignee: Sanofi
    Inventors: Bernard Bourrie, Pierre Casellas
  • Oxaliplatin active substance with a very low content of oxalic acid
    Patent number: 8211940
    Abstract: The present invention relates to an oxaliplatin active substance for a pharmaceutical composition, wherein its weight content in oxalic acid is not more than 0.08%, and to a process of preparing the active substance.
    Type: Grant
    Filed: October 9, 2009
    Date of Patent: July 3, 2012
    Assignee: Debiopharm S.A.
    Inventors: Houssam Ibrahim, Rolland-Yves Mauvernay